progesterone receptor modulates er alpha action breast cancer 
progesterone receptor pr expression used biomarker oestrogen receptor-alpha er alpha function breast cancer prognosis show pr merely er alpha-induced gene target also er alpha-associated protein modulates behaviour presence agonist ligands pr associates er alpha direct er alpha chromatin binding events within breast cancer cells resulting unique gene expression programme associated good clinical outcome progesterone inhibited oestrogen-mediated growth er alpha+ cell line xenografts primary er alpha+ breast tumour explants increased anti-proliferative effects coupled er alpha antagonist copy number loss pgr gene coding pr common feature er alpha+ breast cancers explaining lower pr levels subset cases findings indicate pr functions molecular rheostat control er alpha chromatin binding transcriptional activity important implications prognosis therapeutic interventions 
